Farallon Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-350,000	Closed	-$12.6M	–	113
2019 Q3	$12.6M	Buy	+350,000	New	+$12.6M	0.1%	81
2014 Q3	–	Sell	-70,000	Closed	-$1.58M	–	81
2014 Q2	$1.58M	Hold	70,000	–	–	0.02%	84
2014 Q1	$1.7M	Buy	+70,000	New	+$1.7M	0.03%	75